Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed Nov 14, 2024 · 10-Q · 45 days after period end · 0001477932-24-007198
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$372.22K | -$342.01K | -$4.82M | -$4.45M |
| EPS Diluted | $0.00 | — | -$0.01 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end
